Kneat.com, Inc. (KSI.TO) Research

Kneat.com, Inc. develops and provides specialized software solutions for managing data and documents within highly regulated industries across the United States, Ireland, Canada, and other international markets. Its flagship product, the Kneat Gx platform, is a customizable, ready-to-use application designed to streamline validation lifecycle processes and critical testing procedures specifically for sectors such as biotechnology, pharmaceuticals, and medical device manufacturing. This robust platform supports a wide array of validation activities, including those for processes, computer systems, cleaning, analytical instruments, methods, utilities, facilities, equipment, and cold chains. It also facilitates commissioning, qualification, and electronic logbook management. Beyond its software, Kneat.com offers comprehensive services like user training, system installation, upgrades, ongoing maintenance, consulting, process mapping, and project management. The company's headquarters are located in Limerick, Ireland.

Market snapshot

Symbol
KSI.TO
Price
$6.43
Day change
-0.16%
Market cap
$618.1M
P/E ratio
-72.82x
52-week range
3.23-6.44
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Next earnings
in 1 month

Peer companies

  • Aurora Cannabis Inc. (ACB.TO)
  • Cresco Labs Inc. (CL.CN)
  • Cipher Pharmaceuticals Inc. (CPH.TO)
  • Bright Minds Biosciences Inc. (DRUG.CN)
  • Spectral Medical Inc. (EDT.TO)
  • Knight Therapeutics Inc. (GUD.TO)
  • High Tide Inc. (HITI.V)
  • Vitalhub Corp. (VHI.TO)

Open Kneat.com, Inc. (KSI.TO) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.